Akari Therapeutics Plc (AKTX) stock
AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.65+0.95 (+16.67%)
Close on Nov 18, 2026Market cap $12.95MP/E –Yield –
Akari Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Akari Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$10.76M. For fiscal 2025 it was -$10.57M. The highest annual figure on record is -$366.00K in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.57M | – |
| FY2024 | Dec 31, 2024 | -$12.55M | – |
| FY2023 | Dec 31, 2023 | -$16.43M | – |
| FY2022 | Dec 31, 2022 | -$21.50M | – |
| FY2021 | Dec 31, 2021 | -$18.85M | – |
| FY2020 | Dec 31, 2020 | -$16.95M | – |
| FY2019 | Dec 31, 2019 | -$12.92M | – |
| FY2018 | Dec 31, 2018 | -$22.77M | – |
| FY2017 | Dec 31, 2017 | -$31.60M | – |
| FY2016 | Dec 31, 2016 | -$24.62M | – |
| FY2015 | Dec 31, 2015 | -$4.97M | – |
| FY2014 | Dec 31, 2014 | -$1.48M | – |
| FY2013 | Dec 31, 2013 | -$5.45M | – |
| FY2012 | Dec 31, 2012 | -$2.13M | – |
| FY2011 | Dec 31, 2011 | -$1.01M | – |
| FY2010 | Dec 31, 2010 | -$366.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.11M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.49M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.04M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.15M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.12M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.49M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.89M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.04M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.41M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.45M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.69M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.88M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.23M | – |
| Q3 FY2020 | Sep 30, 2020 | -$704.17K | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.27M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.74M | -3480.6% |
| Q4 FY2019 | Dec 31, 2019 | -$3.46M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.91M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.77M | – |
| Q1 FY2019 | Mar 31, 2019 | $228.94K | -94.9% |
| Q2 FY2016 | Jun 30, 2016 | -$5.69M | – |
| Q1 FY2016 | Mar 31, 2016 | -$7.44M | – |
| Q4 FY2015 | Dec 31, 2015 | -$6.77M | – |
| Q3 FY2015 | Sep 30, 2015 | $4.49M | +25.9% |
| Q2 FY2015 | Jun 30, 2015 | -$697.54K | – |
| Q1 FY2015 | Mar 31, 2015 | -$1.99M | – |
| Q4 FY2014 | Dec 31, 2014 | -$667.98K | – |
| Q3 FY2014 | Sep 30, 2014 | $3.57M | – |
| Q2 FY2014 | Jun 30, 2014 | -$2.33M | – |
See a number that looks wrong?